Related Experiment Videos
Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and kidney transplantation
Insights
Elevated C3d levels are common in glomerulonephritis and renal transplant patients, often linked to kidney function but not directly to immune complexes or transplant rejection. Immunosuppression may lower C3d in transplant recipients.
Area of Science:
- Nephrology
- Immunology
- Clinical Chemistry
Background:
- Circulating immune complexes (CIC) and complement activation products like C3d are implicated in kidney diseases.
- Glomerulonephritis (GN) and renal transplantation involve complex immunological processes.
Purpose of the Study:
- To investigate the levels and significance of CIC and C3d in patients with GN and renal transplants.
- To determine the relationship between CIC, C3d, renal function, and transplant outcomes.
Main Methods:
- Measurement of CIC using a Clq-binding assay.
- Quantification of C3d via double-decker rocket immunoelectrophoresis.
- Analysis in 81 GN patients and 53 renal transplant recipients.
Main Results:
- Elevated C3d was found in 45 GN patients, particularly those with specific types of GN (membranoproliferative, diffuse sclerosing, lupus nephritis, Wegener's).
- No correlation was observed between CIC and C3d levels in GN patients.
- Elevated C3d correlated with impaired renal function and heavy proteinuria, but also with improving function, suggesting complex associations.
- In renal transplant patients, C3d levels normalized within a month post-transplant, and immunosuppressive therapy appeared to reduce C3d.
- CIC and elevated C3d were not predictive of acute rejection or late graft failure.
Conclusions:
- C3d elevation in GN is frequent and associated with renal inflammation and function, but its precise role requires further study.
- CIC and C3d levels do not appear to be reliable markers for predicting rejection or failure in renal transplants.
- C3d levels in renal transplant recipients normalize post-transplant, indicating successful graft function and potentially the impact of immunosuppression.
Abstract:
Circulating immune complexes (CIC) and the complement breakdown product C3d were measured in 81 patients with glomerulonephritis (GN), 28 patients with early and 25 patients with long-term renal transplants. CIC were measured by a Clq-binding assay and C3d by a double-decker rocket immunoelectrophoresis. In patients with GN, CIC were detected in 19 and elevated C3d levels found in 45 patients. The highest levels of C3d were found in patients with membranoproliferative GN type I and II, diffuse sclerosing GN and GN secondary to SLE and Wegener's granulomatosis. No relationship was found between CIC and C3d, and the combination of CIC with C3d measurements did not help to characterize 'nephritogenic' CIC. C3d was frequently elevated in patients with impaired renal function which may reflect an inflammatory 'nephritic' process, but may also be due to a reduced renal elimination. Furthermore C3d was frequently elevated in patients with improving or decreasing renal function, and in patients with heavy proteinuria. Longitudinal studies of renal transplant patients suggested that immunosuppressive treatment decreased the C3d level. Patients with early renal transplants had elevated C3d levels that normalized during the first month after successful transplantation. CIC and elevated C3d were not related to onset of acute rejection episodes in early transplant patients nor to late renal graft failure.